2.92
Schlusskurs vom Vortag:
$2.86
Offen:
$2.91
24-Stunden-Volumen:
40,353
Relative Volume:
0.09
Marktkapitalisierung:
$6.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.58M
KGV:
-2.5391
EPS:
-1.15
Netto-Cashflow:
$-9.80M
1W Leistung:
+11.45%
1M Leistung:
-9.03%
6M Leistung:
-69.71%
1J Leistung:
-86.61%
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Firmenname
Acurx Pharmaceuticals Inc
Sektor
Branche
Telefon
917-533-1469
Adresse
259 LIBERTY AVENUE, STATEN ISLAND
Vergleichen Sie ACXP mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
ACXP
Acurx Pharmaceuticals Inc
|
2.92 | 6.72M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.38 | 113.87B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
776.54 | 80.22B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
406.40 | 52.56B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
803.74 | 49.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.07 | 37.37B | 447.02M | -1.18B | -906.14M | -6.1812 |
Acurx Pharmaceuticals Inc Aktie (ACXP) Neueste Nachrichten
Has Acurx Pharmaceuticals (ACXP) Outpaced Other Medical Stocks This Year? - Yahoo Finance
Acurx Pharmaceuticals Inc 3ZO Stock Analysis and ForecastMerger & Acquisition Updates & Plan Your Future With Strategic Investing - earlytimes.in
Risk Off: Can Acurx Pharmaceuticals Inc stock beat analyst upgradesMarket Volume Summary & Risk Controlled Daily Trade Plans - moha.gov.vn
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Resigns with New to The Street for Long-Form Interviews, National TV Commercials, Earned Media, and Accredited Investor Events - Greenville Online
Aug EndMonth: Why Acurx Pharmaceuticals Inc stock is in analyst buy zone2025 Market Sentiment & Free Expert Approved Momentum Trade Ideas - moha.gov.vn
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Acurx Pharmaceuticals (ACXP) Stock Analysis Report | Financials & Insights - Benzinga
Acurx Pharmaceuticals (NASDAQ:ACXP) Upgraded to “Hold” at Wall Street Zen - Defense World
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Sees Significant Growth in Short Interest - Defense World
Exide Industries Limited Flashes Buy Signal on Multi Timeframe ChartStock Watchlist Updates & High Return Wealth Building - earlytimes.in
What drives Acurx Pharmaceuticals Inc stock priceTechnical Breakout Signals & We Spotted the Next Tesla – See Inside - earlytimes.in
Acurx Pharmaceuticals (NASDAQ:ACXP) Downgraded by Wall Street Zen to Sell - Defense World
Will Acurx Pharmaceuticals Inc. stock remain a Wall Street favorite2025 Major Catalysts & Weekly Top Gainers Trade List - DonanımHaber
Why Acurx Pharmaceuticals Inc. stock remains undervaluedEarnings Risk Summary & Low Drawdown Trading Techniques - DonanımHaber
Why Acurx Pharmaceuticals Inc. stock is in analyst buy zoneJuly 2025 PostEarnings & Real-Time Volume Triggers - DonanımHaber
How Acurx Pharmaceuticals Inc. stock compares to growth peersLong Setup & Real-Time Market Sentiment Reports - DonanımHaber
Why Acurx Pharmaceuticals Inc. (3ZO) stock could break out in 2025July 2025 Selloffs & Accurate Intraday Trading Signals - Улправда
Aug Outlook: Can Acurx Pharmaceuticals Inc stock beat analyst upgradesShare Buyback & Weekly Stock Performance Updates - moha.gov.vn
Is Acurx Pharmaceuticals Inc. stock positioned for long term growthEarnings Summary Report & Weekly Sector Rotation Insights - Улправда
Market Review: Why Acurx Pharmaceuticals Inc. (3ZO) stock could break out in 2025Earnings Overview Summary & Expert Verified Movement Alerts - Улправда
Acurx Pharmaceuticals Earnings Notes - Trefis
Acurx Pharmaceuticals (NASDAQ:ACXP) Shares Down 9.3% – Time to Sell? - Defense World
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat growth indexes2025 Volatility Report & Real-Time Market Trend Scan - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock draw ESG focused fundsWeekly Trend Summary & AI Based Trade Execution Alerts - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock justify high valuation2025 Stock Rankings & Weekly Breakout Stock Alerts - Newser
Is Acurx Pharmaceuticals Inc. stock a defensive play in 2025Entry Point & Verified Short-Term Plans - Newser
Will Acurx Pharmaceuticals Inc. (3ZO) stock beat Nasdaq index returns - Newser
Perhaps timely catching Acurx Pharmaceuticals Inc (ACXP) would be a good idea - Setenews
Wall Street Zen Upgrades Acurx Pharmaceuticals (NASDAQ:ACXP) to Hold - Defense World
Acurx Pharmaceuticals Inc. (ACXP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Why Acurx Pharmaceuticals Inc. (3ZO) stock is upgraded to buy2025 Bull vs Bear & Free Long-Term Investment Growth Plans - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock a defensive play amid uncertaintyInsider Buying & Weekly Market Pulse Alerts - newser.com
Will Acurx Pharmaceuticals Inc. stock benefit from green energy trendsPortfolio Gains Report & Step-by-Step Trade Execution Guides - newser.com
Can Acurx Pharmaceuticals Inc. (3ZO) stock withstand sector downturnsJuly 2025 Fed Impact & Daily Growth Stock Tips - newser.com
What is the fair value of Acurx Pharmaceuticals Inc. stock nowTrade Exit Summary & Long Hold Capital Preservation Tips - newser.com
Is Acurx Pharmaceuticals Inc. stock resilient to inflationTrade Volume Report & High Conviction Buy Zone Picks - newser.com
Is Acurx Pharmaceuticals Inc. (3ZO) stock positioned for digital growth eraEarnings Risk Summary & Safe Entry Zone Tips - newser.com
Why Acurx Pharmaceuticals Inc. (3ZO) stock could be next leaderJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com
Quantitative breakdown of Acurx Pharmaceuticals Inc. recent moveTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
Is this a good reentry point in Acurx Pharmaceuticals Inc.July 2025 Snapshot & Advanced Swing Trade Entry Plans - newser.com
Finanzdaten der Acurx Pharmaceuticals Inc-Aktie (ACXP)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):